Fractyl Health (GUTS) Total Current Liabilities (2023 - 2026)
Fractyl Health (GUTS) reported Total Current Liabilities of $15.4 million for Q1 2026, down 18.05% year-on-year from $18.8 million in Q1 2025, and down 15.94% quarter-over-quarter from $18.3 million in Q4 2025.
Fractyl Health (GUTS) has 4 years of Total Current Liabilities data on file, last reported at $15.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 18.05% year-over-year to $15.4 million; the trailing twelve-month figure through Mar 2026 stood at $15.4 million (down 18.05% YoY), and the FY2025 full-year result was $18.3 million, down 7.31% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $15.4 million, down from $18.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $21.8 million in Q2 2025 and bottomed at $11.2 million in Q4 2023.
- A 4-year average of $16.7 million and a median of $17.0 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 76.75% in 2024 and decreased 18.05% in 2026, its largest moves.
- Tracing GUTS's Total Current Liabilities over 4 years: stood at $11.2 million in 2023, then jumped by 76.75% to $19.8 million in 2024, then slipped by 7.31% to $18.3 million in 2025, then retreated by 15.94% to $15.4 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $15.4 million, $18.3 million, and $18.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 5.11 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 15.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.41 Mn |
| Dec 31, 2025 | 18.33 Mn |
| Sep 30, 2025 | 18.68 Mn |
| Jun 30, 2025 | 21.83 Mn |
| Mar 31, 2025 | 18.80 Mn |
| Dec 31, 2024 | 19.78 Mn |
| Sep 30, 2024 | 15.72 Mn |
| Jun 30, 2024 | 14.28 Mn |
| Mar 31, 2024 | 13.27 Mn |
| Dec 31, 2023 | 11.19 Mn |